Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Bard

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Science Translational Medicine|February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's diseaseDaniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascadeJ Steven Jacobsen, Thomas A Comery, Robert L Martone, et al.
Journal of Medicinal Chemistry|October 13, 2006
Acylguanidines as small-molecule beta-secretase inhibitorsDerek C Cole, Eric S Manas, Joseph R Stock, et al.
Database : the Journal of Biological Databases and Curation|July 15, 2010
Finding and sharing: new approaches to registries of databases and services for the biomedical sciencesDamian Smedley, Paul Schofield, Chao-Kung Chen, et al.
Journal of Medicinal Chemistry|March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitorsJohn Wityak, Kevin F McGee, Michael P Conlon, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 13, 2009
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's diseaseRobert L Martone, Hua Zhou, Kevin Atchison, et al.
Journal of Medicinal Chemistry|December 22, 2022
Design and Evaluation of [<sup>18</sup>F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin AggregatesLongbin Liu, Peter D Johnson, Michael E Prime, et al.
Nature Medicine|July 3, 2019
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's diseaseBryan Zeitler, Steven Froelich, Kimberly Marlen, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Science Translational Medicine|February 2, 2022
Development of a ligand for in vivo imaging of mutant huntingtin in Huntington's diseaseDaniele Bertoglio, Jonathan Bard, Manuela Hessmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2008
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascadeJ Steven Jacobsen, Thomas A Comery, Robert L Martone, et al.
Journal of Medicinal Chemistry|October 13, 2006
Acylguanidines as small-molecule beta-secretase inhibitorsDerek C Cole, Eric S Manas, Joseph R Stock, et al.
Database : the Journal of Biological Databases and Curation|July 15, 2010
Finding and sharing: new approaches to registries of databases and services for the biomedical sciencesDamian Smedley, Paul Schofield, Chao-Kung Chen, et al.
Journal of Medicinal Chemistry|March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitorsJohn Wityak, Kevin F McGee, Michael P Conlon, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 13, 2009
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's diseaseRobert L Martone, Hua Zhou, Kevin Atchison, et al.
Journal of Medicinal Chemistry|December 22, 2022
Design and Evaluation of [<sup>18</sup>F]CHDI-650 as a Positron Emission Tomography Ligand to Image Mutant Huntingtin AggregatesLongbin Liu, Peter D Johnson, Michael E Prime, et al.
Nature Medicine|July 3, 2019
Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington's diseaseBryan Zeitler, Steven Froelich, Kimberly Marlen, et al.
Pageof 8